Difference between revisions of "COVID-19 and emerging viral infections: The case for interferon lambda (DOI: 10.1084/jem.20200653) (Q10304)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: Author (P97): Prokunina-Olsson L (1st author of DOI: 10.1084/jem.20200653) (Q10305), #quickstatements; #temporary_batch_1592857754139)
(‎Created claim: has part (P22): References (from DOI: 10.1084/jem.20200653) (Q11182), #quickstatements; #temporary_batch_1593026963448)
 
(35 intermediate revisions by the same user not shown)
Property / Author: Prokunina-Olsson L (1st author of DOI: 10.1084/jem.20200653) / reference
 +
Property / Author
 +
Property / Author: Alphonse N (2nd author of DOI: 10.1084/jem.20200653) / rank
 +
Normal rank
Property / Author: Alphonse N (2nd author of DOI: 10.1084/jem.20200653) / reference
 +
Property / Author
 +
Property / Author: Dickenson RE (3rd author of DOI: 10.1084/jem.20200653) / rank
 +
Normal rank
Property / Author: Dickenson RE (3rd author of DOI: 10.1084/jem.20200653) / reference
 +
Property / Author
 +
Property / Author: Durbin JE (4th author of DOI: 10.1084/jem.20200653) / rank
 +
Normal rank
Property / Author: Durbin JE (4th author of DOI: 10.1084/jem.20200653) / reference
 +
Property / Author
 +
Property / Author: Glenn JS (5th author of DOI: 10.1084/jem.20200653) / rank
 +
Normal rank
Property / Author: Glenn JS (5th author of DOI: 10.1084/jem.20200653) / reference
 +
Property / Author
 +
Property / Author: Hartmann R (6th author of DOI: 10.1084/jem.20200653) / rank
 +
Normal rank
Property / Author: Hartmann R (6th author of DOI: 10.1084/jem.20200653) / reference
 +
Property / Author
 +
Property / Author: Kotenko SV (7th author of DOI: 10.1084/jem.20200653) / rank
 +
Normal rank
Property / Author: Kotenko SV (7th author of DOI: 10.1084/jem.20200653) / reference
 +
Property / Author
 +
Property / Author: Lazear HM (8th author of DOI: 10.1084/jem.20200653) / rank
 +
Normal rank
Property / Author: Lazear HM (8th author of DOI: 10.1084/jem.20200653) / reference
 +
Property / Author
 +
Property / Author: O'Brien TR (9th author of DOI: 10.1084/jem.20200653) / rank
 +
Normal rank
Property / Author: O'Brien TR (9th author of DOI: 10.1084/jem.20200653) / reference
 +
Property / Author
 +
Property / Author: Odendall C (10th author of DOI: 10.1084/jem.20200653) / rank
 +
Normal rank
Property / Author: Odendall C (10th author of DOI: 10.1084/jem.20200653) / reference
 +
Property / Author
 +
Property / Author: Onabajo OO (11th author of DOI: 10.1084/jem.20200653) / rank
 +
Normal rank
Property / Author: Onabajo OO (11th author of DOI: 10.1084/jem.20200653) / reference
 +
Property / Author
 +
Property / Author: Piontkivska H (12th author of DOI: 10.1084/jem.20200653) / rank
 +
Normal rank
Property / Author: Piontkivska H (12th author of DOI: 10.1084/jem.20200653) / reference
 +
Property / Author
 +
Property / Author: Santer DM (13th author of DOI: 10.1084/jem.20200653) / rank
 +
Normal rank
Property / Author: Santer DM (13th author of DOI: 10.1084/jem.20200653) / reference
 +
Property / Author
 +
Property / Author: Reich NC (14th author of DOI: 10.1084/jem.20200653) / rank
 +
Normal rank
Property / Author: Reich NC (14th author of DOI: 10.1084/jem.20200653) / reference
 +
Property / Author
 +
Property / Author: Wack A (15th author of DOI: 10.1084/jem.20200653) / rank
 +
Normal rank
Property / Author: Wack A (15th author of DOI: 10.1084/jem.20200653) / reference
 +
Property / Author
 +
Property / Author: Zanoni I (16th author of DOI: 10.1084/jem.20200653) / rank
 +
Normal rank
Property / Author: Zanoni I (16th author of DOI: 10.1084/jem.20200653) / reference
 +
Property / has part
 +
Property / has part: Section 1: Introduction (from DOI: 10.1084/jem.20200653) / rank
 +
Normal rank
Property / has part
 +
Property / has part: Section 2: IFNs as natural broad-spectrum antivirals (from DOI: 10.1084/jem.20200653) / rank
 +
Normal rank
Property / has part
 +
Property / has part: Section 3: IFN-lambda as an antiviral drug (from DOI: 10.1084/jem.20200653) / rank
 +
Normal rank
Property / has part
 +
Property / has part: Section 4: COVID-19 treatment by IFN-lambda: Pros and cons (from DOI: 10.1084/jem.20200653) / rank
 +
Normal rank
Property / has part
 +
Property / has part: References (from DOI: 10.1084/jem.20200653) / rank
 +
Normal rank

Latest revision as of 19:29, 24 June 2020

Research article published in J. Exp. Med.; 2020 05 04 ; 217 (5)
Language Label Description Also known as
English
COVID-19 and emerging viral infections: The case for interferon lambda (DOI: 10.1084/jem.20200653)
Research article published in J. Exp. Med.; 2020 05 04 ; 217 (5)

    Statements

    title
    COVID-19 and emerging viral infections: The case for interferon lambda (English)
    1 reference
    data source
    Pubtator Central BioC-JSON formatted article files
     

    Sitelinks

    Retrieved from "http://wikibase.slis.ua.edu/w/index.php?title=Item:Q10304&oldid=226270"